Genmab — Marts 2018

[Helge_LarsenPI-redaktør]

Tusinde tak for den Pauly.

[Helge_LarsenPI-redaktør]

Vi må formode,
at aktiviteten i DDB har noget med warants-aktier at gøre.

[Solsen]

AQR har tigget og bedt DDB om at få lov til at købe dem

[peter12]

Ja de shortere må være lidt lange i ansigtet nu. Tabene nærmer sig 150 mill ?

[Legolas23]

Kan du dele det regnestykke med forummet?

[peter12]

Der er nogle salgspriser man gætter ved at kigge på grafen. Så der er en del usikkerhed. Delte for nogle dage siden

[Helge_LarsenPI-redaktør]

Hej Peter12...Det var super arbejde. Kan du dele det igen?

[peter12]

Der var en lille fejl, så jeg skal løbe det igennem en gang endnu, før jeg deler det igen. Der er vist også kommet flere aktier ?

[StockBull]

Morning https://news.alphastreet.com/is-johnson-johnson-a-sell-in-2018/

[Helge_LarsenPI-redaktør]

God morgen.

[bibob]

God morgen.

[polle1]

God morgen i sneen

[rex_pacis]

God morgen

[E_L]

god morgen. A bit surprised to see this Ofa study on "Pemphigus Vulgaris" set to 'completed' only now https://clinicaltrials.gov/ct2/show/NCT01920477?term=daratumumab+OR+ofatumumab+OR+tisotumab&lupd_s=03%2F06%2F2018&rank=1 while we were told 2 years ago already that it would be discontinued
http://ir.genmab.com/releasedetail.cfm?releaseid=959265

[bibob]

The date is March 8 2016.- so old news.

[Mcjean]

Mere kaffe Bibob https://clinicaltrials.gov/ct2/show/NCT01920477?term=daratumumab OR ofatumumab OR tisotumab&lupd_s=03/06/2018&rank=1 E L har to links

[Bulder]

E L if you look at the changes in the study from may last year, you can see that they have changed from "terminated" to "active not recruiting". So Novartis decided to finish the study without genmab telling us about it.

[bibob]

MJ

[Bulder]

In other words: GSK terminated but Novartis resumed the study.

[E_L]

Bulder, i was reading that just the opposite; as if Novartis kept it alive longer without telling us and was wondering why they would have done that